InspireMD, Inc. — Director's Dealing 2020

Jun 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2020-06-05

Reporting Person: Slosman Marvin (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-05	Common Stock	P	55550	$0.45	Acquired	237931	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-05	Warrants	$0.495	P	55550	Acquired	2025-06-02	Common Stock (55550)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options (right to buy)	$1.10	2030-01-02	Common Stock (60794)	60794	Direct

Footnotes

F1: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit.

F2: 182,381 of these shares of common stock represent restricted stock units ("RSUs"), which vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.

F3: The Reporting Person has not engaged in any reportable transactions with respect to the derivative securities of the Issuer reported in this row and is including his ownership of these securities for informational purposes only in this Form 4.

F4: These stock options vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.